Amneal To Deliver On Three 505(b)(2) Injectables Promise In 2024
The Firm Has Launched Multiple Injectable Products This Year
As the approval stamp dries on the new 505(b)(2) product application, Amneal gets ready to launch its potassium phosphates injection in the third quarter.
